Posted by: Pulse Clinical Team29 October 2013
The Medicines and Healthcare products Regulatory Agency (MHRA) issued a drug alert today asking pharmacies and wholesalers to return some batches of sumatriptan injection- following a manufacturing fault which left some of the needles protruding from the protective shield.
The annoucement came just days after batches of NovoMix 30 insulin pens were also withdrawn die to concerns they contained the wrong dose of insulin.
The affected batches are:
• Imigran injection – C640404, C638748, C636954
• Imigran refill – C639899, C638737
• NovoMix 30 Flexpen 100U/ml pre-filled pen and the Novomix 30 Penfill 100U/ml cartridges - CS6D422, CS6C628, CS6C411, CP50912, CP50750, CP50639, CP51706, CP50940, CP50928, CP50903, CP50914, CP50640, CP51095, CP50904, CP50650, CP51098, CP50915, CP50412, CFG0003, CFG0002, CFG0001, CP50902, CP50749, CP50393, CP50950, CP51025, CP50751, CP50375, CP50420, CP51097, CP50641, CP51096 and CP50392